Prostate Cancer and Prostatic Diseases

(ISSN: 1365-7852, 1476-5608)

This journal no longer participates in Medscape Publishers' Circle Program. No new articles will be republished.

Table of Contents

2020 -

  • Concurrent or layered treatment with radium-223 and enzalutamide or abiraterone/prednisone: real-world clinical outcomes in patients with metastatic castration-resistant prostate cancer. 
  • African-American men with low-risk prostate cancer treated with radical prostatectomy in an equal-access health care system: implications for active surveillance. 
  • High-intensity interval training produces a significant improvement in fitness in less than 31 days before surgery for urological cancer: a randomised control trial. 
  • Survival outcomes and risk group validation from SWOG S0925: a randomized phase II study of cixutumumab in new metastatic hormone-sensitive prostate cancer. 
  • Feasibility of freehand MRI/US cognitive fusion transperineal biopsy of the prostate in local anaesthesia as in-office procedure-experience with 400 patients. 
 
 

Journal Information

Mission Statement: Prostate Cancer and Prostatic Diseases, covering all aspects of prostate disease (including BPH and cancer).